W G Partners
WG
Financial Advisors
W G Partners
85 Gresham St, London EC2V 7NQ
# WG Partners: Specialist Life Sciences Advisory
WG Partners is a boutique corporate advisory firm headquartered in London's financial district, with an additional office in Sydney. The firm specialises exclusively in life sciences, positioning itself at the intersection of scientific innovation and commercial opportunity.
The firm serves corporate and institutional clients seeking guidance on strategic transactions, mergers and acquisitions, and capital formation. Their clientele spans the UK, Europe, USA, Asia and Australia, reflecting their genuinely international reach rather than merely aspirational global ambitions.
What distinguishes WG Partners is the calibre of its leadership and transactional track record. The business is entirely partner-owned, with the founding team bringing collectively over 250 years of sector-specific experience. This ownership structure ensures accountability and long-term commitment to client outcomes. More tangibly, the firm has completed transactions exceeding £8.4 billion in value over the past decade—a substantial volume that demonstrates consistent deal-making capability and market confidence.
Rather than competing on size or general advisory breadth, WG Partners has built a focused practice around life sciences expertise. This specialisation allows them to navigate the sector's unique regulatory, intellectual property, and valuation complexities with greater sophistication than generalist competitors. The depth of experience within the founding team suggests familiarity with both established pharmaceutical and biotech businesses, alongside emerging innovators.
For life sciences companies and investors seeking seasoned, sector-focused advisory support, WG Partners offers rare access to senior experience without the overhead typical of larger institutions.
WG Partners is a boutique corporate advisory firm headquartered in London's financial district, with an additional office in Sydney. The firm specialises exclusively in life sciences, positioning itself at the intersection of scientific innovation and commercial opportunity.
The firm serves corporate and institutional clients seeking guidance on strategic transactions, mergers and acquisitions, and capital formation. Their clientele spans the UK, Europe, USA, Asia and Australia, reflecting their genuinely international reach rather than merely aspirational global ambitions.
What distinguishes WG Partners is the calibre of its leadership and transactional track record. The business is entirely partner-owned, with the founding team bringing collectively over 250 years of sector-specific experience. This ownership structure ensures accountability and long-term commitment to client outcomes. More tangibly, the firm has completed transactions exceeding £8.4 billion in value over the past decade—a substantial volume that demonstrates consistent deal-making capability and market confidence.
Rather than competing on size or general advisory breadth, WG Partners has built a focused practice around life sciences expertise. This specialisation allows them to navigate the sector's unique regulatory, intellectual property, and valuation complexities with greater sophistication than generalist competitors. The depth of experience within the founding team suggests familiarity with both established pharmaceutical and biotech businesses, alongside emerging innovators.
For life sciences companies and investors seeking seasoned, sector-focused advisory support, WG Partners offers rare access to senior experience without the overhead typical of larger institutions.
Services offered
Corporate advisoryMergers and acquisitionsCapital raisingBusiness valuationsStrategic transaction structuringInstitutional investor relationsDue diligence facilitationInternational market entry advisory